Page
%P
-
Chapter
Is the Beta-Blocker DL-ZAMI 1305 a Tumor Promoter for Rat Liver?
A 6-month administration of the beta-adrenoreceptor blocking agent DL-1-(2-nitro-3-methyl-phenoxy)-3-tert-butylamino-propan-2-ol (DL-ZAMI 1305) results in the appearance of metastatic hepatocellular carcinomas...
-
Article
First degree family history of diabetes and risk factors for cardiovascular disease in non-diabetic subjects in the National Telephone Company: A metabolic survey
The effect of first degree family history of diabetes on known risk factors for cardiovascular disease was evaluated in 4989 non-diabetic employees of the Italian Telephone Company. Family history of diabetes ...